mycosis fungoides

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instanceOf gptkb:disease
leukemia
gptkbp:affects gptkb:skin
lymphatic system
gptkbp:associatedWith TCR gene rearrangement
gptkbp:causedBy unknown
gptkbp:complication sepsis
secondary infections
systemic spread
gptkbp:diagnosedBy histopathology
skin biopsy
gptkbp:firstDescribed 1806
gptkbp:hasEpidemiology more common in men
median age at diagnosis 55-60 years
gptkbp:hasTreatmentGoal disease control
symptom relief
gptkbp:hasTypicalOnset adulthood
gptkbp:histology Pautrier microabscesses
atypical lymphocytes
epidermotropism
https://www.w3.org/2000/01/rdf-schema#label mycosis fungoides
gptkbp:ICD-10_code C84.0
gptkbp:mortalityRate increased in advanced stages
gptkbp:namedAfter gptkb:Alibert
gptkbp:originatedIn T lymphocyte
gptkbp:prevalence rare
gptkbp:prognosis variable
gptkbp:riskFactor African descent
male sex
older age
gptkbp:stageName erythrodermic stage
patch stage
plaque stage
tumor stage
gptkbp:symptom tumors
plaques
itching
skin rash
patches
enlarged lymph nodes
gptkbp:synonym Alibert-Bazin syndrome
cutaneous T-cell lymphoma, type MF
gptkbp:treatment radiation therapy
immunotherapy
phototherapy
retinoids
topical corticosteroids
systemic chemotherapy
gptkbp:bfsParent gptkb:leukemia
gptkbp:bfsLayer 5